Maria Bravo

Advanced cell models and multifunctional nanomaterials for light-mediated cancer therapies
Started on October, 2021
Global PhD Partnership (Melbourne University)
email Maria Bravo
Despite significant advances in cancer therapy over the past decades, cancer remains the number one cause of death worldwide. In the last years there has been increasing interest in the development of new treatment modalities with reduced side effects for difficult-to-cure cancers. A prominent example is Photothermal Therapy (PTT), designed to selectively kill cancerous tissue in the body through localized, light-induced thermal stress. The development of nanomaterials marks a significant step forward in photothermal therapy of cancers. Nanomaterials smaller than 200 nm accumulate in the tumour tissue and exhibit strong absorption in the near-infrared range, making them effective photothermal transducers with cancer targeting capabilities. Nanomaterial-mediated PTT has reached clinical trials but knowledge concerning the efficiency, mechanism and toxicity of this therapy remains limited. This project aims to unravel the mechanisms involved in nanomaterial-mediated PTT, using microscopy to monitor intracellular temperature and cell death pathways simultaneously. To mimic the physiological features present in solid tumors most accurately, multicellular tumor spheroids will be used. The fabrication and characterisation of novel nanomaterials will also be a major part of this project, targeting nanosensors for mapping intracellular temperature, and gold-based stimuli-responsive nanocrystals with enhanced solid tumor penetration and efficient photothermal transduction for long-wavelength light. The information obtained thereby will be crucial for the rational design of next-generation nanomaterials for targeted light-mediated cancer therapies. However, as for any novel cancer therapy, before its wide application at the clinical level, it is desired to have a complete understanding of the efficiency, mechanism and toxicity of nanomaterial-based PTT. In this project this will be achieved by developing new nanomaterials, to both induce and probe light-induced hyperthermia. A full understanding of the mechanism behind nanomaterial-mediated PTT requires monitoring the intracellular temperature and cell death pathways during light irradiation. Only a systematic investigation will allow proper adjustment of treatment parameters to achieve the best therapeutic efficiency in solid tumors.
Publications
Maria Bravo, Guillermo SolĂs-Fernandez, Sandra Krzyzowska, Steven Huysecom, Ana Montero-Calle, Indra Van Zundert, Boris Louis, Rodrigo Barderas, Betrice Fortuni, Susana Rocha
Deposited in bioRxiv (see link)
Group paper
Farsai Taemaitree, Yuta Takano, Daisuke Yamaguchi, Kazushi Yamaguchi, Yudai Yamashita, Motosuke Tsutsumi, Chentao Wen, Kohei Otomo, Kenji Hirai, James Andell Hutchison, Indra Van Zundert, Sandra Krzyzowska, Maria Bravo, Sayuki Hirano, Koutarou D Kimura, Kazuhiro Aoki, Susana Rocha, Tomomi Nemoto, Beatrice Fortuni, Hiroshi Uji-i
Deposited in bioRxiv (see link)
Pierre Cybulski, Maria Bravo, Jim Jui-Kai Chen, Indra Van Zundert, Sandra Krzyzowska, Farsai Taemaitree, Hiroshi Uji-i, Johan Hofkens, Susana Rocha, Beatrice Fortuni
Published in Frontiers in Cell and Developmental Biology, January 2025 (see publication in Journal )
Group paper
Maria Bravo, Beatrice Fortuni, Paul Mulvaney, Johan Hofkens, Hiroshi Uji-i, Susana Rocha, James A Hutchison
Published in Journal of Controlled Release, August 2024 (see publication in Journal )
Group paper
Maria Bravo, Shelly Yang, Sam Brooke, Dingchen Wen, Farsai Taemaitree, Samantha Zaman, Hiroshi Uji-i, Susana Rocha, Paul Mulvaney, James A Hutchison
Deposited in bioRxiv (see link)
Group paper
Imran Aslam, Maria Bravo, Indra Van Zundert, Susana Rocha, Maarten BJ Roeffaers
Published in Analytical Chemistry, May 2023 (see publication in Journal or Research Gate )
Indra Van Zundert, Maria Bravo, Olivier Deschaume, Pierre Cybulski, Carmen Bartic, Johan Hofkens, Hiroshi Uji-i, Beatrice Fortuni, Susana Rocha
Published in Pharmaceutics, December 2021 (see publication in Journal )
Deposited in bioRxiv (see link)
Group paper